A recent report 10 from mainland China concluded that HPV DNA testing is highly sensitive and moderately specific for cervical intraepithelial neoplasia 3 or worse (CIN3+; CIN3 is the usual immediate precursor to invasive cervical cancer), with consistent results across study sites and age groups. This paper reviewed reports of more than 30,000 women from population-based screening studies done between 1999 and 2008, with the aim of assessing whether HPV DNA testing could be applied to cervical cancer screening programs in China. About 75 percent of the women tested were between the ages of 30 and 50 years. The studies used.